TRIM33 and hepatocellular carcinoma: An example of this is the upregulation of TRIM33 caused by the action of circSMAD2 and the following decreased expression of SMAD4, which blocks the TGF-β signaling pathway in HCC (hepatocellular carcinoma) cells [40].